|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 31/52 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| C07D 473/34 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07D 487/04 | (2006.01) |
| (11) | Patento numeris | 2272517 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10184485.0 |
| Europos patento paraiškos padavimo data | 2005-10-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-01-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-10-01 |
| (46) | Apibrėžties vertimo paskelbimo data | 2014-11-25 |
| (30) | Numeris | Data | Šalis |
| 0423655 | 2004-10-25 | GB | |
| 621821 P | 2004-10-25 | US | |
| 684119 P | 2005-05-24 | US |
| (72) |
Berdini, Valerio, GB
Boyle, Robert George, GB
Saxty, Gordon, GB
Walker, David Winter, GB
Woodhead, Steven John, GB
Wyatt, Paul Graham, GB
Caldwell, John, GB
Collins, Ian, GB
Da Fonseca , Tatiana Faria, GB
Donald, Alastair, GB
|
| (73) |
Astex Therapeutics Limited,
436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA,
GB
The Institute of Cancer Research: Royal Cancer Hospital, 123 Old Brompton Road, London SW7 3RP, GB Cancer Research Technology Limited, Angel Building 407 St John Street, London EC1V 4AD, GB |
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Orto-kondensuoti piridino ir pirimidino dariniai (pavyzdžiui, purinai) kaip proteinkinazės inhibitoriai |
| Ortho-condensed pyridine and pyrimidine derivatives ( e.g. purines ) as protein kinases inhibitors |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2024-09-23 | 20 | 347.00 EUR |